Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Pacific Northwest Research Institute currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution suggests that the company is pursuing multiple technological paths within the biotechnology sector.
The busiest examiner for this company is ALLEN, SARAH ELIZABETH, who is managing 1 busiest examiner pending action. This examiner is responsible for 1 of the 2 pending office actions. Practitioners must account for the different styles of the 2 distinct examiners when managing the overall prosecution strategy for the 2 pending office actions.
The involvement of 2 distinct art units indicates that the company's applications may touch upon different technical aspects within the Biotechnology & Pharmaceuticals area. This requires a strategy that can adapt to the specific standards of each unit. The 2 pending office actions represent the current active front for the company's intellectual property efforts in this field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALLEN, SARAH ELIZABETH | 1 | 57.1% | +50.0% |
| HOLTZMAN, KATHERINE ANN | 1 | 65.7% | +58.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17047667 | METHODS OF DETECTING AMINO ACID DEFICIENCIES | HOLTZMAN, KATHERINE ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768104 | METHODS OF DETECTING AMINO ACID DEFICIENCIES | ALLEN, SARAH ELIZABETH | 46d overdue |
| 17047667 | METHODS OF DETECTING AMINO ACID DEFICIENCIES | HOLTZMAN, KATHERINE ANN | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17768104 | METHODS OF DETECTING AMINO ACID DEFICIENCIES | ALLEN, SARAH ELIZABETH | 1637 | §103DP | Final Rejection | 46d overdue | Pending | Apr 11, 2022 |
| 17047667 | METHODS OF DETECTING AMINO ACID DEFICIENCIES | HOLTZMAN, KATHERINE ANN | 1646 | §101§103§112DP | Non-Final OA | — | Pending | Oct 14, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial